Mast cells are the central mediating cells of allergic reactions responding via the high-affinity IgE receptor (FcεRI) through binding of IgE and specific antigen (1) . This activation leads to the release of preformed mediators stored in secretory granules (such as histamine, α and β tryptases, and chymase) as well as to the de novo synthesis of leukotrienes and prostaglandins and the production and release of various cytokines and chemokines (1) .
The monitoring of mediator release has been used in the past as a direct measurement of mast cell activation. In particular, assays to detect histamine have long been the standard used for studies of mast cell function (2) (3) (4) (5) (6) . In addition, although the release of the mast cell protease tryptase has been used to monitor mast cell activation, those assays describe a multi-step technique in which tryptase levels are determined at a given endpoint after removal of cells (7, 8) . We report the development of a real-time assay for mast cell tryptase release from small numbers of cells (10 4 cells/assay point). This assay measures the release of tryptase from cells real-time and does not require manipulation of the cells other than incubation with appropriate stimuli.
To propagate human cord blood-derived mast cells (CMBCs), human umbilical cord blood mononuclear progenitors (Poeitic Technologies, Gaithersburg, MD, USA) were placed into culture medium (RPMI/10% FBS; Invitrogen, Carlsbad, CA, USA) in the presence of stem cell factor and IL-6 (R&D Systems, Minneapolis, MN, USA), both at 100 ng/mL, at a density of 1 × 10 6 cells/mL (modification of Reference 9) . One half of the culture medium was changed each week. After five weeks, IL-4 (R&D Systems) was introduced into the medium at 100 ng/mL. Cultures were continued for eight weeks and evaluated by staining with Toluidine blue dye. Cells used for functional assays were a minimum of 90% Toluidine blue positive.
Eight-to ten-week-old CBMCs were lysed by three rounds of freeze/ thaw, and the lysate was diluted in tryptase assay buffer (100 mM TrisHCl, pH 8.0, 100 mM NaCl) in a final volume of 50 µL and placed in the wells of a 96-well plate (Pierce Chemical, Rockford, IL, USA). An additional 50 µL of buffer alone or buffer containing protease inhibitors (all from Sigma St. Louis, MO, USA) was added to each well. A final 50 µL substrate [tosyl-glypro-lys-p-nitroanilide (10) (Sigma), 25 mM stock in 100% DMSO] in buffer was added to a final concentration of 500 µM, and the plate was immediately read in a plate reader (Molecular Devices, Sunnyvale, CA, USA) at 410 nm in the kinetic mode for 15 min with data collection every 30 s. Enzyme activity was determined as the rate of change of A due to cleavage of the substrate (velocity) and reported as mOD/min. The proteolytic activity present in varying numbers of cells against a serine protease substrate (tosyl-gly-pro-lys-p-nitro anilide) is shown in Figure 1 along with the activity of 5 nM rh-β-tryptase (Promega, Madison, WI, USA). Proteolytic activity above background could be detected from as few as 100 cells and was linear with cell number through the range tested (r 2 = 0.99). This protease was inhibited by serine protease inhibitors (antipain, BABIM, benzamidine, leupeptin, and TLCK) and lactoferrin (which inhibits tryptase by competing for heparin) (data not shown) (11) . Cysteine protease inhibitors (aprotinin, pepstatin, and TPCK) were not effective (data not shown). This pattern of inhibition suggests that the proteolytic activity being measured is indeed that of tryptase.
To assay the real-time release of tryptase, CBMCs were sensitized for 24 h or longer in the presence of varying concentrations of human IgE (Biodesign, Saco, ME, USA). Before use, the cells were pelleted for 4 min at 1000× g and resuspended in RPMI at 2 × 10 5 cells/mL. Fifty microliters of cells (approximately 10 000 cells/well) were added to each well of a 96-well plate. Either 50 µL of buffer or buffer containing compounds to be tested was added to each well, and the plate was Various numbers of CBMCs were subjected to three rounds of freeze/thaw, and the cell debris was pelleted. The supernatant was tested for protealytic activity against 500 µM tosyl-gly-pro-lys-para-nitroanilide. rh-β-tryptase was run at 5 nM final concentration. Enzyme activity is indicated as change in A (mOD/min). Values are presented as x -± SEM of three independent experiments performed in triplicate.
incubated at 37°C for 30 min. To activate cells, 50 µL of buffer containing substrate as above along with varying concentrations of sheep anti-human IgE (Biodesign) were added to each well, and the plate was immediately read in a plate reader at 410 nm in the kinetic mode for 45 min with data collection every 30 s. Figure 2 shows the time-dependent increase in A due to the release of tryptase after activation of the cells by anti-IgE, as well as control cells with no anti-IgE stimulation. In stimulated cells, there is an initial lag of 7-10 min (likely due to the time it takes to accumulate sufficient tryptase) and a plateau occurring at approximately 30 min (due to limiting substrate). The velocity of the change in A (mOD/min) within the linear portion of the curve (from about 12 min through about 22 min) was used in subsequent analyses as the measure of mast cell tryptase release. The observed increase in A in the unstimulated cells is due to the small amount of tryptase that is spontaneously released from cells. Figure 3 shows dose responses of tryptase release by anti-IgE at various IgE concentrations. Maximal activation of the cells occurred with 0.1 µg/mL IgE with no detectable activation at 0.0001 µg/mL IgE (Figure 3) . The EC 50 values for anti-IgE were 51 ± 15, 56 ± 7.3, 145 ± 60, and 167 ± 43 ng/mL, respectively, for 1, 0.1, 0.01, and 0.001 µg/mL IgE (Figure 3) . When the data were analyzed in a reciprocal manner, the EC 50 values for IgE were 1.7 ± 0.3, 2.3 ± 0.4, 3.4 ± 0.3, 5.1 ± 0.8, 7.9 ± 1.8, 17.6 ± 3.2, and 26 ± 7.8 ng/mL, respectively, for 10, 3, 1, 0.3, 0.1, 0.03, and 0.01 µg/mL anti-IgE.
A real-time tryptase release assay has been developed. The profile of inhibition of the proteolytic activity released by these cells is consistent with tryptase activity. Tryptase is released by activation of FcεRI in a time-and dosedependent manner (Figures 2 and 3 ). This homogeneous real-time assay requires small numbers of cells, few processing steps, and offers the possibility of high-throughput screening because it is formatted in 96 wells. In addition, this assay allows for the simultaneous identification of both inhibitors and activators of mast cells without alteration of the assay format. The initial lag in activity (Figure 2 ) allows for the identification of activators when compounds are pre-incubated with cells. Using this real-time assay, the EC 50 values for both IgE and anti-IgE for release of tryptase from CBMCs were determined. Additionally, the maximal amount of tryptase released through FcεRI was compared with that released by calcium ionophore (data not shown). These amounts were equivalent, which is consistent with previous studies (12) in which the percent histamine release through FcεRI was found to be 100% of that released by ionophore from cells cultured in IL-4. The amount of tryptase released in our studies was typically 10%-20% of total tryptase consistent with 10%-20% histamine release from the same cultures. In addition, this assay has been used to examine tryptase release mediated by endothelin-1, platelet activating factor, phorbol ester, and ATP (data not shown). This methodology should also be applicable to mast cells isolated from other species; however, the protease profile of these mast cells will have to be characterized. This assay will be useful to screen for modulators of tryptase release from CBMCs and will allow the identification of both inducers and inhibitors of release.
Double-Color Fluorescence In Situ Hybridization with RNA Probes
BioTechniques 34: 914-918 (May 2003) In situ hybridization is a useful tool for localization and partial quantification of gene expression. However, the method is costly and laborious, especially when used to measure the expression of multiple genes. Most previously reported protocols for doublelabeled fluorescence probes involve DNA probe labeling (1,2). The disadvantages of using DNA probes are lower sensitivity and higher background signals. Some methods for double-labeled RNA probes have also been reported, but most involve radioactive probes (3, 4) . Here we report the development of a unique method of doublecolor fluorescence in situ hybridization (FISH) using RNA probes.
Previous studies have indicated the expression of specific isoforms of sulfonylurea receptors in subpopulations of dopamine-containing cells of the substantia nigra (5) . We took advantage of this information to demonstrate the
